Prostate cancer is the most common form of cancer among men in England, with cases surging by 25 per cent between 2019 and 2023, according to NHS data. It’s also the second-deadliest form of the ...

THIS YEAR, IT’S estimated that nearly 300,000 new prostate cancer cases will be diagnosed. While there’s no single test to detect prostate cancer, doctors commonly use the prostate-specific antigen ...

The NHS will not be inviting all men over a certain age to be checked for prostate cancer like it does for some other cancers. The UK National Screening Committee has recommended that the prostate ...

The understanding of prostate cancer has significantly evolved in the past 15 years. Therefore, many people — including primary care providers — may not be aware of the current guidelines for prostate ...

The use of prostate-specific antigen (PSA) testing for prostate cancer screening remains the subject of scientific debate. Experts are unable to agree on how to balance the benefit of such testing ...

Editor's note: Dr. Jamin Brahmbhatt is a urologist and robotic surgeon with Orlando Health and an assistant professor at the University of Central Florida’s College of Medicine.When I learned that ...

In a recent study published in Nature Medicine, researchers conducted a genome-wide analysis of prostate-specific antigen (PSA) levels of men without prostate cancer to understand the ...

Over the past 15 years, public health authorities have downgraded recommendations for the prostate-specific antigen (PSA) test as a screening tool to reduce the overdiagnosis and overtreatment of men ...